Optimizationvia experimental design of an SPE-HPLC-UV-fluorescence method for the determination of valsartan and its metabolite in human plasma samples-Reference-Cited by-同舟云学术

Optimizationvia experimental design of an SPE-HPLC-UV-fluorescence method for the determination of valsartan and its metabolite in human plasma samples

Published:2006-10 Issue:15 Volume:29 Page:2265-2283
ISSN:1615-9306
Container-title:Journal of Separation Science
language:en
Short-container-title:J. Sep. Sci.

Author:

Iriarte Gorka,Ferreirós Nerea,Ibarrondo Izaskun,Alonso Rosa Maria,Maguregi Miren Itxaso,Gonzalez Lorena,Jiménez Rosa Maria

Publisher

Wiley

Subject

Filtration and Separation,Analytical Chemistry

Reference57 articles.

1. Absolute bioavailability and pharmacokinetics of valsartan, an angiotensin II receptor antagonist, in man

2. Valsartan: Preclinical and Clinical Profile of an Antihypertensive Angiotensin-II Antagonist

3. The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension

4. Valsartan

5. Patterns of antihypertensive therapy in new users of angiotensin II-receptor blockers

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapid methylation of valsartan in human plasma using evaporative derivatization reagent to improve its sensitivity in MALDI-TOF mass spectrometry;Analytical Methods;2022

2. Integrated Analytical Quality by Design (AQbD) Approach for the Development and Validation of Bioanalytical Liquid Chromatography Method for Estimation of Valsartan;Journal of Chromatographic Science;2020-07-13

3. HPLC method transfer study for simultaneous determination of seven angiotensin II receptor blockers;Journal of Separation Science;2020-02-16

4. Simultaneous magnetic dispersive micro solid phase extraction of valsartan and atorvastatin using a CMC-coated Fe3O4 nanocomposite prior to HPLC-UV detection: multivariate optimization;New Journal of Chemistry;2019

5. An overview of experimental designs in HPLC method development and validation;Journal of Pharmaceutical and Biomedical Analysis;2018-01